Form 4 for AKBA Akebia Therapeutics, Inc.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001562180-22-002165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-02 | 2022-02-28+ | AKBA | Burke Steven Keith | SVP, Chief Medical Off | S - Sale | $2.16 | -15.1K | 217.7K | -6% | -$32.5K |
| D | 2022-03-02 | 2022-02-28 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +60.0K | 223.8K | +37% | $0 |
| D | 2022-03-02 | 2022-02-28 | AKBA | Burke Steven Keith | SVP, Chief Medical Off | A - Grant | $0.00 | +225.0K | 225.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | S | D | 7,400 | $2.15 | 163,819 | D | — | — | (F1) This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. |
| 2 | Common | Common Stock | 2022-02-28 | A | A | 60,000 | $0.00 | 223,819 | D | — | — | (F2) The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. |
| 3 | Common | Common Stock | 2022-03-01 | S | D | 6,556 | $2.17 | 217,263 | D | — | — | (F3) This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020. |
| 4 | Common | Common Stock | 2022-03-01 | S | D | 1,100 | $2.17 | 217,663 | D | — | — | (F4) This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021. (F5) Includes 1,500 shares of the Issuers common stock purchased on December 31, 2021, under the Issuers 2014 Amended and Restated Employee Stock Purchase Plan. |
| 5 | Derivative | Employee Stock Option (Right to buy) | 2022-02-28 | A | A | 225,000 | $0.00 | 225,000 | D | $2.16 · — to 2032-02-28 | 225,000 Common Stock | (F6) The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. |